AV

Amol Vijayrao Nalwade

Active Director Director DIN 08064509
DIN 08064509 First appointment Feb 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Amol Vijayrao Nalwade

Data last updated:

Amol Vijayrao Nalwade is a Director at Pams Medithrive Global Private Limited (since 2018). The company operates in Pharma.

DIN 08064509
Primary Designation Director
Industry Pharma
First Appointment 01 Feb 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Feb 20182018Active

Directorship timeline

Open interactive timeline →
Pams Medithrive Global Private Limited
Premium access

Shareholding and investment profile for Amol Vijayrao Nalwade

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amol Vijayrao Nalwade

Amol Vijayrao Nalwade currently holds 1 directorship: Pams Medithrive Global Private Limited (Director, since 01 Feb 2018).

Amol Vijayrao Nalwade was first appointed on 01 Feb 2018 as Director at Pams Medithrive Global Private Limited.

The current boards of Amol Vijayrao Nalwade's companies include Manisha Shekhar Jagtap (Pams Medithrive Global Private Limited), Prakash Rangrao Patil (Pams Medithrive Global Private Limited), Prithviraj Jayavantrao Deshmukh (Pams Medithrive Global Private Limited), Tejaswi Anil Patil (Pams Medithrive Global Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available